Spark Therapeutics' vision-loss gene therapy to cost $850,000 per patient
(Reuters) - Spark Therapeutics Inc said on Wednesday it would charge $850,000 per patient for its gene therapy to treat a rare form of blindness, lesser than analysts' expectation of around $1 million.
from Reuters: Health News http://reut.rs/2qk0irY
http://bit.ly/2zwRqiM